Company news

#BIO2024!
Thank you to everyone who visited us at the ChemDiv, Inc. booth in the California Pavilion.

ChemDiv, Inc. is coming to #BIO2024! Join us at the California Pavilion booth #2625 or connect with us through the Partnering System.

ChemDiv, Inc, announced today that Bill Farley, CEO, will participate in the EF Hutton Annual Global Conference (https://efhutton.com/conference/). The conference is being held in person at Th...

Last week, our team had the incredible opportunity to attend the Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.

Excited for AACR 2024, we invite you to meet our executive team, led by CEO Bill Farley.

Last week, our ChemDiv team, Michael Nyman, Roman Timakhov, and Aleksandra Khotimchenko, had the incredible opportunity to attend the Drug Discovery Chemistry conference in sunny San Diego.

We're thrilled to announce that our team members, Roman Timakhov and Aleksandra Khotimchenko, will be attending the Drug Discovery Chemistry in San Diego, April 1-4.

42nd Annual JPM Healthcare Conference, held from January 8th to 11th, 2024, in San Francisco, CA.

ChemDiv Marks a Milestone as Orionis Biosciences' Novel Immunotherapy Enters Phase I Clinical Trials

To Expand Its High-throughput Screening Research Capabilities.

ChemDiv Inc., dedicated to partnering in discovery and development of breakthrough therapies based on its unique chem-bio platforms, announces successful completion of Phase I clinical trials for AV51...

Veteran Pharma and Biotech Executive Bill Farley Named New CEO of ChemDiv